247 related articles for article (PubMed ID: 20796232)
1. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
[TBL] [Abstract][Full Text] [Related]
2. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
[TBL] [Abstract][Full Text] [Related]
4. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
Jung J; Park JS; Righesso L; Pabst AM; Al-Nawas B; Kwon YD; Walter C
Clin Oral Investig; 2018 Sep; 22(7):2527-2534. PubMed ID: 29388023
[TBL] [Abstract][Full Text] [Related]
5. Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.
Walter C; Klein MO; Pabst A; Al-Nawas B; Duschner H; Ziebart T
Clin Oral Investig; 2010 Feb; 14(1):35-41. PubMed ID: 19294435
[TBL] [Abstract][Full Text] [Related]
6. The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: An in vitro study.
Pabst AM; Krüger M; Ziebart T; Jacobs C; Sagheb K; Walter C
J Craniomaxillofac Surg; 2015 Jun; 43(5):688-95. PubMed ID: 25913629
[TBL] [Abstract][Full Text] [Related]
7. Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
Otto M; Lux C; Schlittenbauer T; Halling F; Ziebart T
Oral Maxillofac Surg; 2022 Jun; 26(2):321-332. PubMed ID: 34392434
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo.
Draenert GF; Huetzen DO; Kämmerer PW; Palarie V; Nacu V; Wagner W
J Craniomaxillofac Surg; 2012 Dec; 40(8):e369-74. PubMed ID: 22429609
[TBL] [Abstract][Full Text] [Related]
10. Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt.
Bezzi M; Hasmim M; Bieler G; Dormond O; Rüegg C
J Biol Chem; 2003 Oct; 278(44):43603-14. PubMed ID: 12933798
[TBL] [Abstract][Full Text] [Related]
11. Effects of pamidronate on human alveolar osteoblasts in vitro.
Marolt D; Cozin M; Vunjak-Novakovic G; Cremers S; Landesberg R
J Oral Maxillofac Surg; 2012 May; 70(5):1081-92. PubMed ID: 21856057
[TBL] [Abstract][Full Text] [Related]
12. Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw.
Ziebart T; Koch F; Klein MO; Guth J; Adler J; Pabst A; Al-Nawas B; Walter C
Oral Oncol; 2011 Mar; 47(3):195-201. PubMed ID: 21247791
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
Hagelauer N; Ziebart T; Pabst AM; Walter C
Clin Oral Investig; 2015 Jun; 19(5):1079-91. PubMed ID: 25261400
[TBL] [Abstract][Full Text] [Related]
14. In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.
Tanaka Y; Nagai Y; Dohdoh M; Oizumi T; Ohki A; Kuroishi T; Sugawara S; Endo Y
Arch Oral Biol; 2013 Jun; 58(6):628-37. PubMed ID: 23245859
[TBL] [Abstract][Full Text] [Related]
15. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
Cozin M; Pinker BM; Solemani K; Zuniga JM; Dadaian SC; Cremers S; Landesberg R; Raghavan S
J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
[TBL] [Abstract][Full Text] [Related]
17. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
[TBL] [Abstract][Full Text] [Related]
18. Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.
Jacobs C; Walter C; Ziebart T; Dirks I; Schramm S; Grimm S; Krieger E; Wehrbein H
Clin Oral Investig; 2015 Apr; 19(3):699-708. PubMed ID: 25055746
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
Fromigué O; Body JJ
J Endocrinol Invest; 2002 Jun; 25(6):539-46. PubMed ID: 12109626
[TBL] [Abstract][Full Text] [Related]
20. Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Sade Hoefert C; Munz A; Schmitz I; Grimm M; Yuan A; Northoff H; Reinert S; Alexander D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):222-32. PubMed ID: 26725718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
